X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10129) 10129
Publication (737) 737
Newsletter (194) 194
Book Review (108) 108
Newspaper Article (42) 42
Book Chapter (20) 20
Conference Proceeding (8) 8
Transcript (6) 6
Dissertation (4) 4
Magazine Article (4) 4
Data Set (3) 3
Book / eBook (2) 2
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7624) 7624
methotrexate (6325) 6325
female (4816) 4816
index medicus (4753) 4753
male (4543) 4543
middle aged (3382) 3382
adult (3068) 3068
methotrexate - therapeutic use (2857) 2857
rheumatology (2738) 2738
rheumatoid arthritis (2656) 2656
treatment outcome (2162) 2162
arthritis, rheumatoid - drug therapy (2148) 2148
aged (2111) 2111
immunology (2068) 2068
antirheumatic agents - therapeutic use (1712) 1712
methotrexate - administration & dosage (1507) 1507
oncology (1494) 1494
animals (1473) 1473
arthritis (1451) 1451
therapy (1431) 1431
adolescent (1329) 1329
hematology (1285) 1285
care and treatment (1225) 1225
drug therapy, combination (1193) 1193
child (1108) 1108
immunosuppressive agents - therapeutic use (1088) 1088
double-blind (1068) 1068
rheumatoid-arthritis (1041) 1041
rheumatoid factor (1011) 1011
drug therapy (996) 996
medicine & public health (995) 995
infliximab (985) 985
patients (956) 956
transplantation (952) 952
research (906) 906
arthritis, rheumatoid - immunology (898) 898
methotrexate - adverse effects (896) 896
chemotherapy (873) 873
disease (817) 817
analysis (813) 813
cancer (804) 804
etanercept (794) 794
methotrexate - pharmacology (794) 794
retrospective studies (793) 793
risk factors (789) 789
tumor necrosis factor-alpha - antagonists & inhibitors (745) 745
antibodies, monoclonal - therapeutic use (740) 740
child, preschool (716) 716
efficacy (702) 702
severity of illness index (691) 691
antirheumatic agents - adverse effects (678) 678
health aspects (658) 658
mice (653) 653
inflammation (627) 627
pharmacology & pharmacy (627) 627
children (626) 626
time factors (612) 612
medical research (584) 584
follow-up studies (576) 576
antineoplastic combined chemotherapy protocols - therapeutic use (571) 571
prognosis (565) 565
clinical trials (563) 563
young adult (555) 555
dermatology (536) 536
safety (521) 521
dosage and administration (520) 520
research article (513) 513
cyclosporine (512) 512
remission (503) 503
psoriasis (499) 499
antirheumatic agents - administration & dosage (497) 497
prospective studies (490) 490
trial (481) 481
dose-response relationship, drug (479) 479
adalimumab (478) 478
diagnosis (478) 478
remission induction (471) 471
graft vs host disease - prevention & control (468) 468
leukemia (468) 468
pediatrics (459) 459
medicine, experimental (447) 447
transplantation, homologous (446) 446
abridged index medicus (437) 437
expression (436) 436
aged, 80 and over (434) 434
cytokines (420) 420
rituximab (419) 419
cyclophosphamide (416) 416
risk (412) 412
medicine (406) 406
corticosteroids (399) 399
studies (396) 396
monoclonal-antibody (394) 394
tumor necrosis factor (394) 394
monoclonal antibodies (393) 393
cyclophosphamide - therapeutic use (389) 389
drugs (389) 389
infant (385) 385
drug administration schedule (382) 382
immunosuppressive agents - adverse effects (382) 382
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10060) 10060
German (105) 105
Japanese (61) 61
French (49) 49
Russian (45) 45
Chinese (29) 29
Italian (23) 23
Spanish (23) 23
Polish (13) 13
Hungarian (12) 12
Dutch (5) 5
Korean (4) 4
Portuguese (4) 4
Danish (3) 3
Hebrew (2) 2
Norwegian (2) 2
Swedish (2) 2
Czech (1) 1
Finnish (1) 1
Icelandic (1) 1
Romanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 10/2013, Volume 72, Issue 10, pp. 1605 - 1612
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0120327
Traditional treatments, including a variety of thermal therapies have been known since ancient times to provide relief from rheumatoid arthritis (RA) symptoms.... 
SYNOVIAL INFLAMMATION | COLLAGEN-INDUCED ARTHRITIS | LPS-STIMULATED MACROPHAGES | HYPOXIA-INDUCIBLE FACTOR | EARLY RHEUMATOID-ARTHRITIS | ALPHA MESSENGER-RNA | MULTIDISCIPLINARY SCIENCES | FEBRILE-RANGE TEMPERATURE | GENE-EXPRESSION | FACTOR-KAPPA-B | NECROSIS-FACTOR INHIBITORS | Methotrexate - pharmacology | Arthritis, Experimental - therapy | NF-kappa B - metabolism | Arthritis, Experimental - pathology | Heat-Shock Proteins - genetics | STAT1 Transcription Factor - metabolism | T-Lymphocytes - metabolism | Hyperthermia, Induced | Antibodies - immunology | Antirheumatic Agents - pharmacology | Joints - metabolism | Macrophages - immunology | Disease Models, Animal | Cytokines - metabolism | Joints - drug effects | Macrophage Activation - immunology | Heat-Shock Proteins - metabolism | Joints - pathology | Arthritis, Experimental - immunology | Combined Modality Therapy | Arthritis, Rheumatoid - pathology | Arthritis, Rheumatoid - therapy | Macrophages - metabolism | Animals | Joints - immunology | T-Lymphocytes - immunology | Mice | Arthritis, Rheumatoid - immunology | Rheumatoid factor | Collagen | Heat shock proteins | Models | Arthritis | Comparative analysis | Methotrexate | Health aspects | Heat treatment | Animal models | Clinical trials | Kinases | Macrophages | Cancer therapies | Immunology | Rodents | Animal tissues | Tumor necrosis factor-TNF | Medical research | NF-κB protein | Cytokines | Inflammation | Hsp70 protein | Pharmacology | Tumor necrosis factor-α | Gene expression | Joint diseases | Disease control | Fever | Studies | Heat | Government agencies | Rheumatoid arthritis | Interleukin 10 | Hypoxia | Infiltration | Laboratory animals | Autoimmune diseases | Hyperthermia | Binding sites
Journal Article
The Journal of Rheumatology, ISSN 0315-162X, 02/2007, Volume 34, Issue 2, pp. 272 - 279
Journal Article
The AAPS Journal, ISSN 1550-7416, 3/2017, Volume 19, Issue 2, pp. 377 - 385
Journal Article
Molecules, ISSN 1420-3049, 01/2017, Volume 22, Issue 1, p. 134
A disruption of the crucial balance between regulatory T-cells (Tregs) and Th17-cells was recently implicated in various autoimmune disorders. Tregs are... 
Autoimmunity | Foxp3 | Regulatory T-Cells | Th17-cells | Rorγt | COLLAGEN-INDUCED ARTHRITIS | ROR-GAMMA-T | SARILUMAB PLUS METHOTREXATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PATHOGENIC T(H)17 CELLS | regulatory T-cells | CHEMISTRY, MULTIDISCIPLINARY | ACTIVE PSORIATIC-ARTHRITIS | GROWTH-FACTOR-BETA | autoimmunity | TRANSCRIPTION FACTOR FOXP3 | RORt | PLACEBO-CONTROLLED TRIAL | ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY | Forkhead Transcription Factors - immunology | Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors | Humans | Interleukin-17 - immunology | Antibodies, Monoclonal - therapeutic use | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Autoimmune Diseases - genetics | Th17 Cells - drug effects | Forkhead Transcription Factors - antagonists & inhibitors | Pyrroles - therapeutic use | Autoimmune Diseases - pathology | Autoimmune Diseases - drug therapy | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Th17 Cells - pathology | Nuclear Receptor Subfamily 1, Group F, Member 3 - immunology | Signal Transduction | Autoimmune Diseases - immunology | Gene Expression Regulation | Interleukin-17 - genetics | Inflammation | Forkhead Transcription Factors - genetics | Ustekinumab - therapeutic use | T-Lymphocytes, Regulatory - drug effects | Animals | Interleukin-17 - antagonists & inhibitors | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Th17 Cells - immunology | Immunologic Factors - therapeutic use | Disruption | Maintenance | Autoimmune diseases | Disorders | RORγt
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 280
Background: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | SPECTRUM DISORDERS | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | CEREBROSPINAL-FLUID | AQUAPORIN-4 ANTIBODIES | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | NEUROSCIENCES | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Journal Article
Clinical Immunology, ISSN 1521-6616, 2017, Volume 184, pp. 77 - 81
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 06/2015, Volume 67, Issue 6, pp. 1629 - 1636
Journal Article